PDF 

Faculty and ESO Advanced Breast Cancer Task Force


CHAIRS

         
        Fatima Cardoso
Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, PT


         
        Alberto Costa
Scientific Director, European School of Oncology, Milan IT and Bellinzona, CH


         
        Larry Norton
Breast Cancer Programs, Memorial Sloan-Kettering Cancer Centre, New York, US


         
        Eric P. Winer
Breast Oncology Center, Dana-Farber Cancer Institute, Boston, US


         


FACULTY AND PANEL MEMBERS

Matti S. Aapro
IMO Clinique De Genolier, Institut Multidisciplinaire d'Oncologie, Genolier, CH

Fabrice André
Department of Medical Oncology, Gustave Roussy Institute, Villejuif, FR

Rajendra A. Badwe
Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, IN

Carlos H. Barrios
Department of Medicine, PUCRS School of Medicine, Porto Allegre, BR

Jonas Bergh
Department of Oncology, Karolinska Institute, Stockholm, SE

Laura Biganzoli
Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, IT

Kimberley L. Blackwell
Breast Cancer Clinical Program, Duke Cancer Institute, Durham, US

David A. Cameron
Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK

Maria João Cardoso
Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, PT

Tanja Cufer
University Clinic of Respiratory & Allergic Diseases Golnik, Golnik, SL

Nagi S. El Saghir
NK Basile Cancer Institute, American University of Beirut Medical Center, Beirut, LB

Lesley Fallowfield
Sussex Health Outcomes Research & Education in Cancer, Brighton & Sussex Medical School, University of Sussex, Brighton, UK

Doris Fenech
Breast Care Support Group, Europa Donna Malta, Mtarfa, MT

Prudence A. Francis
Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, AU

Karen Gelmon
Department of Medical Oncology, BC Cancer Agency, Vancouver, CA

Joseph Gligorov
Department of Medical Oncology, CancerEst APHP Tenon, University Paris VI, Paris, FR

Sharon H. Giordano
Department of Breast Medical Oncology, UT MD Anderson Cancer Centre, Houston, US

Nadia Harbeck
Breast Center, University of Munich, Munich, DE

Nehmat Houssami
Screening and Test Evaluation Program (STEP), Sydney Medical School, University of Sydney, AU

Clifford A. Hudis
Breast and Imaging Center, Memorial Sloan-Kettering Cancer Centre, New York, US

Bella Kaufman
Breast Cancer Unit, Sheba Medical Center, Tel Hashomer, Israel, IL

Ian E. Krop
Breast Oncology Center, Dana-Farber Cancer Institute, Boston, US

Stella Kyriakides
Europa Donna Cyprus, Nicosia, CY

Nancy U. Lin
Breast Oncology Center, Dana-Farber Cancer Institute, Boston, US

Joan Massagué
Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, US

Musa Mayer
AdvancedBC.org, New York, US

Sofia D. Merajver
University of Michigan Medical School and School of Public Health, Ann Arbor, US

Anwar R. Padhani
Cancer Imaging, Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, UK

Olivia Pagani
Department of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, CH

Ann H. Partridge
Department of Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, US

Frédérique Pernault-Llorca
Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, FR

Martine J. Piccart
Department of Medicine, Jules Bordet Institute, Brussels, BE

Kathy Redmond
Cancer World Magazine, Editor, Lugano, CH

Hope S. Rugo
Breast Oncology and Clinical Trials Education, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, US 

Elzbieta Senkus-Konefka
Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, PL

George W. Sledge
Division of Oncology, Stanford School of Medicine, Stanford, US

Christoph Thomssen
Clinic for Gynaecology, Martin-Luther-Universität, Klinikum Kröllwitz, Halle (Saale), DE

Laura van’t Veer
Breast Oncology Program, University of California, San Francisco, US

Conny Vrieling
Department of Radiotherapy, Eaux Vives Oncology Centre, Geneva, CH

Nicola West
Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK

Binghe Xu
Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, CN


CONSENSUS PANELLISTS

Matti S. Aapro, CH
Fabrice André, FR
Rajendra A. Badwe, IN
Carlos H. Barrios, BR
Jonas Bergh, SE
Laura Biganzoli, IT
Kimberley L. Blackwell, US
David A. Cameron, UK
Maria João Cardoso, PT
Tanja Cufer, SL
Nagi S. El Saghir, LB
Lesley Fallowfield, UK
Doris Fenech, MT
Prudence A. Francis, AU
Karen Gelmon, CA
Joseph Gligorov, FR
Sharon H. Giordano, US
Nadia Harbeck, DE
Nehmat Houssami, AU
Clifford A. Hudis, US
Bella Kaufman, IL
Ian E. Krop, US
Stella Kyriakides, CY
Nancy U. Lin, US
Musa Mayer, US
Sofia D. Merjaver, US
Anwar R. Padhani, UK
Olivia Pagani, CH
Ann H. Partridge, US
Frédérique Pernault-Llorca
, FR
Martine J. Piccart, BE
Hope S. Rugo, US 
Elzbieta Senkus-Konefka, PL
George W. Sledge, US
Christoph Thomssen, DE
Laura van’t Veer, US
Conny Vrieling, CH
Nicola West, UK



ESO ADVANCED BREAST CANCER TASK FORCE
 
Coordinators: 

Fatima Cardoso
Breast Cancer Unit, Champalimaud Cancer Center, Lisbon PT

and

Eric P. Winer
Breast Oncology Center, Dana-Farber Cancer Institute, Boston US


 ***

David A. Cameron
Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK

Alberto Costa
Scientific Director, European School of Oncology, Milan, IT and Bellinzona, CH

Tanja Cufer
University Clinic of Respiratory & Allergic Diseases Golnik, Golnik, SL

Lesley Fallowfield
Sussex Health Outcomes Research & Education in Cancer, Brighton & Sussex Medical School, University of Sussex, Brighton, UK

Prudence A. Francis
Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, AU

Joseph Gligorov
Department of Medical Oncology, CancerEst APHP Tenon, University Paris VI, Paris, FR

Stella Kyriakides
Europa Donna Cyprus, Nicosia CY

Nancy U. Lin
Breast Oncology Center, Dana-Farber Cancer Institute, Boston, US

Olivia Pagani
Department of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, CH

Elzbieta Senkus-Konefka
Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, PL

Christoph Thomssen
Clinic for Gynaecology, Martin-Luther-Universität, Klinikum Kröllwitz, Halle (Saale), DE



ESO PATIENT ADVOCACY COMMITTEE

Coordinators: 

Fatima Cardoso
Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, PT

Kathy Redmond
Cancer World Magazine, Editor, Lugano, CH

***

Dian “CJ” M. Corneliussen-James
METAvivor Research and Support, Annapolis, US

Susan Knox
Europa Donna, Milan, IT

Amelia Pinto Leite
Europa Donna, Portugal, Lisbon, PT

Musa Mayer
AdvancedBC.org, New York, US

Shirley Mertz
Metastatic Breast Cancer Network US, Inverness, US

Maxine Morand
Australian Breast Cancer Network Victoria, Camberwell, AU

Kimberly A. Sabelko
Komen Foundation, Dallas, US


 
           
             

 

                             
                             
 
                         
 



Breast Cancer Patient advocacy programme

Representatives of breast cancer patient advocacy groups are warmly invited to participate in ABC2 and actively contribute to the scientific programme and consensus sessions.
Furthermore, in collaboration with several leading breast cancer patient advocacy groups worldwide, specific additional Meet the Expert sessions have been scheduled.

ESO is grateful to Susan G. Komen for the Cure for having provided an unrestricted grant to support the patient advocacy programme.